Brigit Greystoke

927 total citations · 1 hit paper
9 papers, 698 citations indexed

About

Brigit Greystoke is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Brigit Greystoke has authored 9 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Brigit Greystoke's work include Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Brigit Greystoke is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). Brigit Greystoke collaborates with scholars based in United Kingdom, Australia and Mexico. Brigit Greystoke's co-authors include Tim C. P. Somervaille, Allan M. Jordan, Donald Ogilvie, Yaoyong Li, Xu Huang, James R. Hitchin, James T. Lynch, Filippo Ciceri, Gary J. Spencer and William J. Harris and has published in prestigious journals such as PLoS ONE, Cancer Cell and Oncogene.

In The Last Decade

Brigit Greystoke

9 papers receiving 685 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells

2012 432 citations William J. Harris, Xu Huang et al. Cancer Cell profile →

Peers

Brigit Greystoke

MB

HEMAT

CVPR

ONCOL

AI

Sylvia Chien United States

Nathan Martin United States

Helena Hohtari Finland

Walter de Back Germany

Luke T. Dang United States

Christoph Bartenhagen Germany

Alexander Brobeil Germany

Francesco Strino United States

Zhiyao Zhang China

Sylvia Chien United States

Brigit Greystoke

131 ×0.3

MB

142 ×0.6

HEMAT

17 ×0.2

CVPR

68 ×0.9

ONCOL

30 ×0.4

AI

Citations per year, relative to Brigit Greystoke Brigit Greystoke (= 1×) peers Sylvia Chien

Countries citing papers authored by Brigit Greystoke

Since Specialization

Citations

This map shows the geographic impact of Brigit Greystoke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigit Greystoke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigit Greystoke more than expected).

Fields of papers citing papers by Brigit Greystoke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigit Greystoke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigit Greystoke. The network helps show where Brigit Greystoke may publish in the future.

Co-authorship network of co-authors of Brigit Greystoke

This figure shows the co-authorship network connecting the top 25 collaborators of Brigit Greystoke. A scholar is included among the top collaborators of Brigit Greystoke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigit Greystoke. Brigit Greystoke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Dinah, Christiana, et al.. (2024). Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK. BMJ Open. 14(2). e082471–e082471. 1 indexed citations

2.

Moloney, Eoin, D Barge, A. Joy Allen, et al.. (2019). Efficiency and Health Economic Evaluations of BD OneFlow™ Flow Cytometry Reagents for Diagnosing Chronic Lymphoid Leukemia. Cytometry Part B Clinical Cytometry. 96(6). 514–520. 5 indexed citations

3.

McGregor, Andrew, et al.. (2016). Pathological fracture due to lytic lesion caused by a myeloid neoplasm with FIP1L1‐PDGFRA. British Journal of Haematology. 174(5). 660–660. 2 indexed citations

4.

Neoh, Siew Chin, Li Zhang, Stephen Todryk, et al.. (2015). An Intelligent Decision Support System for Leukaemia Diagnosis using Microscopic Blood Images. Scientific Reports. 5(1). 14938–14938. 108 indexed citations

5.

Wiseman, Daniel H., Brigit Greystoke, & Tim C. P. Somervaille. (2013). The variety of leukemic stem cells in myeloid malignancy. Oncogene. 33(24). 3091–3098. 49 indexed citations

6.

White, Daniel J., Richard D. Unwin, Eric M. Bindels, et al.. (2013). Phosphorylation of the Leukemic Oncoprotein EVI1 on Serine 196 Modulates DNA Binding, Transcriptional Repression and Transforming Ability. PLoS ONE. 8(6). e66510–e66510. 38 indexed citations

7.

Huang, Xu, James T. Lynch, James R. Hitchin, et al.. (2012). The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells. Cancer Cell. 21(6). 856–856. 15 indexed citations

8.

Harris, William J., Xu Huang, James T. Lynch, et al.. (2012). The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells. Cancer Cell. 21(4). 473–487. 432 indexed citations breakdown →

9.

Greystoke, Brigit, Sonia Bonanomi, Maged I. Gharib, et al.. (2008). Treosulfan‐containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non‐malignant disease and significant co‐morbidities. British Journal of Haematology. 142(2). 257–262. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact